Patterns of failure and histopathologic outcome predictors following definitive radiotherapy and planned neck dissection with residual disease

Head and Neck

Volumn 34, Issue 7, 2012, Pages 913-922

  Huang, Shao Hui ^a   O'Sullivan, Brian ^a   Weinreb, Ilan ^b   Perez Ordonez, Bayardo ^b   Irish, Jonathan ^c   Waldron, John ^a   Gullane, Patrick ^c   Gilbert, Ralph ^c   Brown, Dale ^c   Cummings, Bernard ^a   Kim, John ^a   Freeman, Jeremy ^c   Witterick, Ian ^c   Goldstein, David ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Head and neck cancer; Outcomes; Pattern of failure; Planned neck dissection; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM METASTASIS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84862838067     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21854     Document Type: Article

References (27)

1. Ferlito A, Corry J, Silver CE, Shaha AR, Thomas Robbins K, Rinaldo A. Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. Head Neck 2010;32: 253-261.
2. Lango MN, Andrews GA, Ahmad S, et al. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis. Head Neck 2009;31:328-337.
3. Yovino S, Settle K, Taylor R, et al. Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapy. Head Neck 2010;32:46-52.
4. Ravasz LA, Slootweg PJ, Hordijk GJ, Smit F, van der Tweel I. The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma. J Craniomaxillofac Surg 1991;19:314-318.
5. Barona de Guzman R, Martorell MA, Basterra J, Armengot M, Alvarez-Valdes R, Garin L. Prognostic value of histopathological parameters in 51 supraglottic squamous cell carcinomas. Laryngoscope 1993;103: 538-540. (Pubitemid 23136180)
6. Hirabayashi H, Koshii K, Uno K, et al. Extracapsular spread of squamous cell carcinoma in neck lymph nodes: prognostic factor of laryngeal cancer. Laryngoscope 1991;101:502-506.
7. Wang ZH, Million RR, Mendenhall WM, Parsons JT, Cassisi NJ. Treatment with preoperative irradiation and surgery of squamous cell carcinoma of the head and neck. Cancer 1989;64:32-38. (Pubitemid 19167133)
8. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005;27: 843-850. (Pubitemid 41395696)
9. van der Putten L, van den Broek GB, de Bree R, et al. Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation. Head Neck 2009;31:593-603.
10. Waldron J, Warde P, Irish J, et al. A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancer. Radiother Oncol 2008;87: 173-180.
11. Radiation Therapy Oncology Group (RTOG). A phase III trial of concurrent radiation and chemotherapy (followed by surgery for residual primary / N2-3 nodal disease) for advanced head and neck carcinomas. 2004 ed: RTOG; 2004.
12. Wong K, Huang SH, O'Sullivan B, et al. Point-of-care outcome assessment in the cancer clinic: audit of data quality. Radiother Oncol 2010;95: 339-343.
13. Greene FL, Page DL, Fleming ID, Fritz AG. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
14. Sobin L, Wittekind C. Head and Neck Tumors. International Union Against Cancer (UICC): TNM classification of malignant tumours. New York: Wiley-Liss; 2002. pp19-43.
15. Peters LJ, O'Sullivan B, Giralt J, et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J Clin Oncol 2010; 28:2996-3001.
16. Jackson SM, Hay JH, Flores AD. Local control of T3N0 glottic carcinoma by 60 Gy given over five weeks in 2.4 Gy daily fractions. One more point on the biological effective dose (BED) curve. Radiother Oncol 2001;59: 219-220. (Pubitemid 32452316)
17. U.S.National Institutes of Health. Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumors (PET PREVENT Trial). ClinicalTrials.gov; 2005.
18. Shrime MG, Bachar G, Lea J, et al. Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity. Head Neck 2009;31:1482-1488.
19. Boyd TS, Harari PM, Tannehill SP, et al. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck 1998;20:132-137. (Pubitemid 28106225)
20. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31: 1341-1346.
21. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
22. Pintilie M. Analysing and interpreting competing risk data. Stat Med 2007;26:1360-1367. (Pubitemid 46380846)
23. Shonka DC Jr, Shoushtari AN, Thomas CY, et al. Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status. Arch Otolaryngol Head Neck Surg 2009;135:1126-1132.
24. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006;24: 736-747. (Pubitemid 46622040)
25. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
26. Shi W, Kato H, Perez-Ordonez B, et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol 2009;27:6213-6221.
27. Pignon JP, le Maitre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4-14.